VitaCholine Ingredients Now Non-GMO Project Verified
Balchem Corp. said that its VitaCholine line of choline chloride and choline bitartrate ingredients have been verified non-GMO by the Non-GMO Project.
Photo © iStockphoto.com/mipan
Balchem Corp. (New Hampton, NY) announced that its VitaCholine line of choline chloride and choline bitartrate ingredients have been verified non-GMO by the Non-GMO Project. VitaCholine ingredients target a range of health categories, including prenatal care, cardiovascular health, memory, energy, and more.
In a press release from Balchem, Tom Druke, director, VitaCholine brand development, Balchem Human Nutrition and Pharma, explained that the new verification will help meet consumer demand for independently verified ingredients stateside, as well as boost the company’s sales efforts overseas. Said Druke: “When consumers purchase a product containing VitaCholine, these certifications are a mark of our high quality, safety, and transparency in manufacturing. And with 60 countries around the world having restrictions or bans on GMO products, this facilitates our international sales efforts.”
In the press statement, Balchem stated that third-party verification is increasingly important to consumers and industry alike, as it certifies that a product has been thoroughly evaluated for compliance with standards developed by industry experts and stakeholders. In addition, third-party verification is an “important mark of quality for product labeling.”
Courtney Pineau, associate director, the Non-GMO Project, added: “The Non-GMO Project celebrates Balchem's achievements in verifying a variety of its products and their commitment to providing consumers a transparent choice in the marketplace.”
Balchem added that in addition to the Non-GMO Project verification, it also participates in the USP Dietary Ingredient Verification Program. That program includes GMP facility auditing, ingredient quality control, and manufacturing documentation review. More information about the company’s third-party certifications can be found on its website.
Also read:
National Institutes of Health Awards Grant to Assess Choline Status
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.
